COLONIC NEOPLASMS
Clinical trials for COLONIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new COLONIC NEOPLASMS trials appear
Sign up with your email to follow new studies for COLONIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called TNhYP218 CAR T cells for people with solid tumors that have high levels of a protein called mesothelin, including mesothelioma. Participants' own immune cells are collected, modified in a lab to better attack cancer, and then gi…
Matched conditions: COLONIC NEOPLASMS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Belly fat and colon cancer: which surgery works best?
Disease control Recruiting nowThis study looks at whether keyhole surgery (laparoscopic) or traditional open surgery leads to better long-term results for colon cancer patients who have extra belly fat. About 664 adults aged 18 to 75 with colon cancer and a high Body Roundness Index will take part. The main g…
Matched conditions: COLONIC NEOPLASMS
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a single drug replace chemo for some colon cancers?
Disease control Recruiting nowThis phase 3 trial tests the immunotherapy drug dostarlimab against standard chemotherapy in 892 people with a specific type of colon cancer (dMMR/MSI-H) that has not spread. The goal is to see if dostarlimab alone can prevent cancer from coming back or causing death. Participant…
Matched conditions: COLONIC NEOPLASMS
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Simple stool test could revolutionize colon cancer screening
Diagnosis Recruiting nowColon cancer is common but preventable if caught early. While colonoscopy is the best screening tool, many people can't get one due to cost or time. This study collects stool and blood samples from 1,200 adults to find proteins that signal colon polyps or cancer. The goal is to d…
Matched conditions: COLONIC NEOPLASMS
Sponsor: University of Michigan Rogel Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Mailed kits and text reminders could save lives in rural cancer screening
Prevention Recruiting nowThis study tests ways to improve colorectal cancer screening in Appalachia by mailing fecal immunochemical test (FIT) kits to 500 people who are due for screening. Some participants get an enhanced kit with a video brochure and gloves, plus phone or text reminders. The goal is to…
Matched conditions: COLONIC NEOPLASMS
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Walking through chemo: exercise may boost treatment success in colon cancer
Symptom relief Recruiting nowThis study looks at whether aerobic exercise can help people with stage II or III colon cancer tolerate more of their planned chemotherapy. About 219 participants who have had surgery and are about to start chemo will be randomly assigned to an exercise program or a control group…
Matched conditions: COLONIC NEOPLASMS
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Scientists revisit endoscopic cancer removal to find best techniques
Knowledge-focused Recruiting nowThis study looks back at medical records of 2000 adults who had endoscopic removal of cancerous or precancerous growths in the esophagus, stomach, duodenum, colon, or rectum. The goal is to compare different removal methods to see which works best and has the fewest complications…
Matched conditions: COLONIC NEOPLASMS
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC